feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate",https://benzinga.com/general/biotech/22/07/28079913/the-daily-biotech-pulse-fda-signs-off-cancer-therapy-trials-for-neximmune-omega-therapeutics-endo,https://bit.ly/3z5kijs
